The federal government is expected to boost COVID-19 vaccine doses to states by about 16% next week to stem nationwide shortages. The weekly dose allocation is expected to increase from 8.6 million to 10 million. (The Washington Post)

Regeneron says its monoclonal antibody cocktail is effective in preventing COVID-19 infection. The company plans to discuss early results with U.S. health regulators, which could lead to emergency use authorization for the drug. (Reuters)

The Federal Trade Commission has sued Endo and Impax Laboratories. The agency alleges that the companies made an illegal deal to create a monopoly for an opioid painkiller. (STAT)

Nestlé Health Science will collaborate with Senda Biosciences on therapies for obesity and glycemia. Senda said the company has gathered enough preclinical animal data to show that its molecule compounds can assist in weight loss and glucose clearing. (Endpoints News)

South Africa President Cyril Ramaphosa called for the world’s richest countries to stop “hoarding” COVID-19 vaccines. “Ending the pandemic worldwide will require greater collaboration on the rollout of vaccines, ensuring that no country is left behind in this effort,” he said Tuesday. (CNBC Weekly)